Loading...

ENOV - Enovis Corporation

Analyst Coverage Initiated Signal for 06-16-2022
Analyst Coverage Initiated: ENOV rating Equal Weight by Wells Fargo
Price Target: $61



Stock Signal Information


Signal

Analyst Coverage Initiated Stock
Report Date: 06-16-2022
Symbol: ENOV - Enovis Corporation
Sector: Industrials
Industry: Specialty Industrial Machinery
Analyst Coverage Initiated: ENOV rating Equal Weight by Wells Fargo
Price Target: $61

  ENOV Technical Chart

Company Contact

Enovis Corporation (ENOV)
2711 Centerville Road
Wilmington, DE 19808
Phone: 302 252 9160
Website: https://www.enovis.com
CEO:


Company Profile

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.